Caribou Biosciences, Inc. (NASDAQ:CRBU) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David E. Johnson Other companies: Vera Therapeutics, Inc. (Chief Operating Officer · Since at least Jul 1, 2024); Exelixis, Inc. (Director · Since at least May 31, 2023); Liquidia Corporation (Board Member · Since at least Apr 13, 2021); AMAG Pharmaceuticals Inc (Director · Oct 8, 2019 – Nov 16, 2020 · Past); Global Blood Therapeutics Inc (Chief Commercial Officer · Mar 13, 2018 – Oct 5, 2022 · Past) | Chief Operating Officer · Since at least May 11, 2022 |
| Natalie Sacks Other companies: Harpoon Therapeutics Inc (Chief Medical Officer · Feb 7, 2019 – Jan 28, 2022 · Past); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Aduro Biotech Inc (Chief Medical Officer · Aug 31, 2016 – Sep 12, 2018 · Past) | Partner at Novo Holdings Ventures Investment · Since at least Jul 22, 2021 |
| Jason V. O'Byrne Other companies: Olema Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Aug 11, 2026); Vir Biotechnology, Inc. (EVP & Chief Financial Officer · Since at least Oct 2, 2024) | Chief Financial Officer · Jul 22, 2021 – Feb 20, 2024 · Past |
| Rachel Haurwitz Other companies: Seer, Inc. (Director · Nov 8, 2021 – Jun 12, 2024 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 11, 2016 · Past) | President and chief executive officer · Since at least Jul 22, 2021 |
| Sriram Ryali Other companies: Codexis, Inc. (Chief Financial Officer · Jan 23, 2023 – Jan 1, 2024 · Past); Eiger Biopharmaceuticals Inc (Chief Financial Officer · Dec 17, 2018 – Mar 14, 2022 · Past) | Chief Financial Officer · Since at least Jan 2, 2025 |
| Syed Ali-aamir Rizvi Other companies: Rocket Pharmaceuticals, Inc. (Chief Medical Officer · Since at least Sep 15, 2025); Poseida Therapeutics Inc (Chief Medical Officer · Apr 1, 2024 – Jan 8, 2025 · Past) | Chief Medical Officer · Jan 18, 2022 – Feb 21, 2023 · Past |
| Andrew Guggenhime Other companies: Vaxcyte, Inc. (PRESIDENT AND CFO · Since at least Oct 18, 2023) | Director · Since at least Feb 20, 2024 |
| Nancy Whiting Other companies: Boundless Bio, Inc. (Director · Since at least Mar 27, 2024) | President and Chief Executive Officer · Since at least Aug 24, 2021 |
| Tina M Albertson Other companies: Lyell Immunopharma, Inc. (Chief Medical Officer · Mar 23, 2022 – Feb 24, 2023 · Past) | Chief Medical Officer · Since at least Aug 12, 2024 |
| Barbara McClung | Chief Legal Officer and Corporate Secretary · Since at least Feb 20, 2024 |
| Dara Richardson-Heron | Chief Executive Officer · Since at least Nov 4, 2021 |
| Enrique Zudaire | Senior Vice President, Translational Research · Since at least Nov 4, 2026 |
| Jeffrey Stephen Long-McGie | Director · Jul 22, 2021 – Jul 22, 2021 · Past |
| Justin Skoble | Senior Vice President, Technical Operations · Since at least Nov 4, 2026 |
| Ran Zheng | Chief Executive Officer · Since at least Sep 24, 2021 |
| Reigin Zawadzki | Chief People Officer · Since at least Nov 4, 2026 |
| Ruhi Ahmad Khan | Chief Business Officer · Since at least Nov 8, 2021 |
| Ryan Fischesser | VP of Finance and Controller · Jul 22, 2021 – Nov 20, 2024 · Past |
| Scott Braunstein | Operating Partner · Since at least Nov 5, 2026 |
| Sri Ryali | Chief Financial Officer · Since at least Jan 12, 2025 |
| Steven Kanner | Chief Scientific Officer · Jul 22, 2021 – Feb 20, 2025 · Past |
| Timothy P Kelly | Chief Technology Officer · Since at least Jan 1, 2024 |
| Tina Albertson | Chief Medical Officer · Since at least Mar 31, 2026 |